Clinical Evaluation and Cost-Effectiveness Analysis of Serum Tumor Markers in Lung Cancer

Table 1

Patient characteristics.

	Lung cancer group (132)	Pulmonary benign disease group (48)	Normal group (92)
Gender
Male	88	28	48
Female	44	20	44
Age	28~81 (54.6)	22~82 (56.3)	18~82 (53.5)
Lung cancer
Histology
Adenocarcinoma	68
Squamous cell lung cancer	56
Small cell lung cancer	8
NSCLC stages
I/II	73
III/IV	51
SCLC stages
Limited disease	3
Extensive disease	5
Pulmonary benign disease
Pneumonia		14
Pleural effusion		12
Bronchiectasia		4
Pulmonary abscess		2
Phthisis		16